PT-141
Bremelanotide (Vyleesi)
Strongsexual_health
Community score3.50 reviews · 0 tracking
FDA-approved as Vyleesi for hypoactive sexual desire disorder in premenopausal women. A melanocortin receptor agonist that works centrally rather than vasodilation. Effective in randomized trials; off-label community use is broad.
For research and personal log purposes. peptidio does not sell, ship, prescribe, or endorse any peptide for the prevention, treatment, or cure of any condition.